ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Iowa » Internal Medicine

Top Internal Medicine Prescribers in Iowa

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MICHAEL O'CONNER DO

Internal Medicine

32,791

$1.56M

953
832 are 65+

13%
patients receiving schedule two controlled substances

Avg: 5%

24%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$48
Average prescription price

Avg: $50

JAMES KWIRANT M.D.

Internal Medicine

21,628

$821K

560
461 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

16%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$38
Average prescription price

Avg: $50

ROSELLER LIBARNES MD

Internal Medicine

20,801

$818K

675
566 are 65+

8%
patients receiving schedule two controlled substances

Avg: 5%

13%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$39
Average prescription price

Avg: $50

STEVEN SEPTER MD

Internal Medicine

20,677

$1.04M

766
667 are 65+

7%
patients receiving schedule two controlled substances

Avg: 5%

18%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$50
Average prescription price

Avg: $50

SUHEIL BARAKAT M.D.

Internal Medicine

20,638

$954K

646
589 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

12%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$46
Average prescription price

Avg: $50

STEVEN REEVES M.D.

Internal Medicine

20,263

$797K

641
559 are 65+

7%
patients receiving schedule two controlled substances

Avg: 5%

14%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$39
Average prescription price

Avg: $50

STEVEN ELLISON MD

Internal Medicine

19,978

$713K

597
506 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

16%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 24%

$36
Average prescription price

Avg: $50

EDWARD PILLER MD

Internal Medicine

19,455

$837K

472
439 are 65+

3%
patients receiving schedule two controlled substances

Avg: 5%

11%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$43
Average prescription price

Avg: $50

BETHEL KOPP M.D.

Internal Medicine

19,171

$761K

706
625 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

10%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$40
Average prescription price

Avg: $50

PAUL BARBER MD

Internal Medicine

18,988

$782K

548
486 are 65+

3%
patients receiving schedule two controlled substances

Avg: 5%

10%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$41
Average prescription price

Avg: $50

GARY DEVOSS M.D.

Internal Medicine

18,851

$1.06M

481
444 are 65+

9%
patients receiving schedule two controlled substances

Avg: 5%

14%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 24%

$56
Average prescription price

Avg: $50

ANDREA RIES M.D.

Internal Medicine

17,581

$651K

631
588 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

16%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$37
Average prescription price

Avg: $50

DAVID LUCKE MD

Internal Medicine

17,231

$725K

599
559 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

7%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$42
Average prescription price

Avg: $50

LOUIS SCHNEIDER D.O.

Internal Medicine

17,036

$872K

663
587 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

11%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$51
Average prescription price

Avg: $50

STEVEN KARBER M.D.

Internal Medicine

16,747

$755K

592
537 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

11%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$45
Average prescription price

Avg: $50

DEANNA QUESTAD MD

Internal Medicine

16,457

$705K

571
522 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

13%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$43
Average prescription price

Avg: $50

MAURICE CHAMPION M.D.

Internal Medicine

16,407

$503K

590
545 are 65+

3%
patients receiving schedule two controlled substances

Avg: 5%

7%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 24%

$31
Average prescription price

Avg: $50

TZE CHAN DO

Internal Medicine

16,367

$718K

875
635 are 65+

7%
patients receiving schedule two controlled substances

Avg: 5%

22%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$44
Average prescription price

Avg: $50

FREDERICK OVROM M.D.

Internal Medicine

16,363

$566K

626
583 are 65+

3%
patients receiving schedule two controlled substances

Avg: 5%

9%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 24%

$35
Average prescription price

Avg: $50

KIN-KWAN CHEUK M.D.

Internal Medicine

15,081

$634K

265
223 are 65+

14%
patients receiving schedule two controlled substances

Avg: 5%

27%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 24%

$42
Average prescription price

Avg: $50

MICHAEL MAHONEY M.D.

Internal Medicine

14,930

$645K

626
541 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

13%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$43
Average prescription price

Avg: $50

SHARMINI RASAKULASURIAR MD

Internal Medicine

14,763

$546K

564
486 are 65+

7%
patients receiving schedule two controlled substances

Avg: 5%

13%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$37
Average prescription price

Avg: $50

KEVIN CROWLEY M.D.

Internal Medicine

14,467

$633K

493
438 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

11%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$44
Average prescription price

Avg: $50

ISAM MARAR M.D.

Internal Medicine

14,088

$892K

486
305 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

7%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 24%

$63
Average prescription price

Avg: $50

MOANIS OMAR M.D.

Internal Medicine

13,729

$758K

451
190 are 65+

8%
patients receiving schedule two controlled substances

Avg: 5%

49%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 24%

$55
Average prescription price

Avg: $50

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank